Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma
Clinical trial NCT00360854 · UNKNOWN
Trial details
- NCT number
- NCT00360854
- Sponsor
- Children's Cancer and Leukaemia Group
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.